Literature DB >> 15161608

Rifapentine for the treatment of tuberculosis: is it all it can be?

Fred M Gordin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15161608     DOI： 10.1164/rccm.2403005

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  3 in total

1.  Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.

Authors:  Ian M Rosenthal; Kathy Williams; Sandeep Tyagi; Charles A Peloquin; Andrew A Vernon; William R Bishai; Jacques H Grosset; Eric L Nuermberger
Journal:  Am J Respir Crit Care Med       Date:  2006-03-30       Impact factor: 21.405

2.  Targeting antibiotic resistance mechanisms in Mycobacterium tuberculosis: recharging the old magic bullets.

Authors:  Liem Nguyen
Journal:  Expert Rev Anti Infect Ther       Date:  2012-09       Impact factor: 5.091

3.  Modelling the long-acting administration of anti-tuberculosis agents using PBPK: a proof of concept study.

Authors:  R K R Rajoli; A T Podany; D M Moss; S Swindells; C Flexner; A Owen; M Siccardi
Journal:  Int J Tuberc Lung Dis       Date:  2018-08-01       Impact factor: 2.373
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.